The future of biologic coatings for orthopaedic implants

SB Goodman, Z Yao, M Keeney, F Yang - Biomaterials, 2013 - Elsevier
Implants are widely used for orthopaedic applications such as fixing fractures, repairing non-
unions, obtaining a joint arthrodesis, total joint arthroplasty, spinal reconstruction, and soft …

Diretriz da Sociedade Brasileira de Cardiologia e da Sociedade Brasileira de Hemodinâmica e Cardiologia Intervencionista sobre intervenção coronária percutânea

F Feres, RA Costa, D Siqueira, JR Costa Jr… - Arquivos brasileiros de …, 2017 - SciELO Brasil
A Cardiologia Intervencionista tem experimentado extraordinário avanço nos últimos anos,
sendo atualmente o método de revascularização do miocárdio mais empregado em todos …

Intravascular ultrasound versus angiography-guided drug-eluting stent implantation: the ULTIMATE trial

J Zhang, X Gao, J Kan, Z Ge, L Han, S Lu… - Journal of the American …, 2018 - jacc.org
Abstract Background: Intravascular ultrasound (IVUS)-guided drug-eluting stent (DES)
implantation is associated with fewer major adverse cardiovascular events compared with …

[PDF][PDF] 2014 ESC/EACTS Guidelines on myocardial revascularization

S Windecker, P Kolh, F Alfonso… - Kardiologia Polska …, 2014 - journals.viamedica.pl
Zachęca się pracowników opieki zdrowotnej, aby w pełni uwzględniali te wytyczne
ESC/EACTS, gdy dokonują oceny klinicznej, a także kiedy określają i realizują medyczne …

ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force on the management of ST …

Authors/Task Force Members, PG Steg… - European heart …, 2012 - academic.oup.com
The task of developing ESC Guidelines covers not only the integration of the most recent
research, but also the creation of educational tools and implementation programmes for the …

6-versus 24-month dual antiplatelet therapy after implantation of drug-eluting stents in patients nonresistant to aspirin: the randomized, multicenter ITALIC trial

M Gilard, P Barragan, AAL Noryani, HA Noor… - Journal of the American …, 2015 - jacc.org
Background: The currently recommended duration of dual antiplatelet therapy (DAPT) in
drug-eluting stent (DES) recipients is 12 months to reduce the risk of late stent thrombosis …

Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: mixed treatment comparison meta …

S Bangalore, B Toklu, N Amoroso, M Fusaro, S Kumar… - Bmj, 2013 - bmj.com
Objective To compare the efficacy and safety of biodegradable polymer drug eluting stents
with those of bare metal stents and durable polymer drug eluting stents. Design Mixed …

Effect of biolimus-eluting stents with biodegradable polymer vs bare-metal stents on cardiovascular events among patients with acute myocardial infarction: the …

L Raeber, H Kelbaek, M Ostojic, A Baumbach, D Heg… - Jama, 2012 - jamanetwork.com
Context The efficacy and safety of drug-eluting stents compared with bare-metal stents
remains controversial in patients with ST-segment elevation myocardial infarction (STEMI) …

Clinical outcomes with drug-eluting and bare-metal stents in patients with ST-segment elevation myocardial infarction: evidence from a comprehensive network meta …

T Palmerini, G Biondi-Zoccai, D Della Riva… - Journal of the American …, 2013 - jacc.org
Objectives: The authors investigated the relative safety and efficacy of different drug-eluting
stents (DES) and bare metal stents (BMS) in patients with ST-segment elevation myocardial …

Guía de práctica clínica de la ESC para el manejo del infarto agudo de miocardio en pacientes con elevación del segmento ST: Grupo de Trabajo para el manejo del …

G Steg, SK James, D Atar, LP Badano… - Revista española de …, 2013 - pure.hud.ac.uk
ESC clinical practice guidelines for the management of acute myocardial infarction in
patients with ST segment elevation: Working Group for the management of acute myocardial …